Park Ha Biological Technology Co., Ltd. (BYAH)

Price$2.52Cached quote
BYAHNasdaq
Loading local price history

Financial charts

Net income

Total cash / debt

CashTotal debt

Financial statements

5 annual periodsNewest to oldest
20252024202320222021
Revenue$2.5M$2.4M$2.5M$1.9M—
Gross profit$2.4M$2.2M$2.1M$1.4M—
Gross margin94.36%91.80%87.35%73.47%—
Research & development$238,184$36,714$30,881$60,671—
Operating expenses$26.5M$1.4M$967,559$1.2M—
Operating income−$24.1M$793,714$1.2M$197,024—
Operating margin−956.45%33.32%48.01%10.26%—
EBITDA−$24.0M$816,400$1.2M$227,515—
EBITDA margin−952.12%34.28%48.82%11.85%—
Net income−$24.4M$478,561$852,042$191,298—
Net profit margin−965.00%20.09%34.65%9.97%—
Basic EPSper basic share-$41.38$0.96$1.70$0.01-$0.93
Diluted EPSper diluted share-$41.38$0.96$1.70$0.01-$0.93

Owners

Reported shareholders

Reference date Jun 30, 2026

Reported holdings Number of shares

View holders
Top 4 reported holders of BYAH
HolderShares held
Virtu Financial LLC
28.44K
MORGAN STANLEY
25.02K
Caitong International Asset Management Co., Ltd
3
ROYAL BANK OF CANADA
1

Bars compare reported share counts. A matching total for this share class and reporting period is unavailable, so percentages are not shown.

Source: SEC Form 13F ↗Updated Sep 29, 2026 · Quarterly data

Insider buys & sells

Jul 1, 2024–Jun 30, 2026
Buys0$0.00 disclosed value
Sells (SEC code S)0$0.00 disclosed value
0 recent transactions
No insider transactions transactions were reported in the stored SEC coverage.

Community posts

It’s quiet here.

No posts about BYAH yet. Start the conversation.

Write the first post